Profile
Thuja Capital is a venture capital firm based in Leiden, Netherlands, founded in 2007 by Harrold van Barlingen. The firm is focused on investing in life science companies, particularly within the biotech and medtech sectors. Their team includes experienced venture partners like Michel Briejer and Evan Castiglia who bring extensive backgrounds in healthcare investments and operations. Thuja Capital's approach is notable for its hands-on strategic and operational support along with its deep network in academia and industry.
The firm targets early-stage investments in companies that address significant unmet medical needs through groundbreaking science and technology. Their typical stages of investment include pre-seed and seed, with a focus on regions such as Europe.
Notable investments by Thuja Capital include CardiacBooster, a medtech company focusing on cardiovascular solutions, NightBalance, acquired by Philips, and other ventures in biotechnology and medtech spaces. Their portfolio reflects their commitment to translating scientific research into clinical practice, leveraging their sector expertise and collaborative approach.
Industry
Thuja Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Magnolia MedTech Fund
|
Venture Capital (VC)
|
Digital
Healthcare Services
MedTech
|
Pre-seed
|
Europe
|
$0-1 m
|
—
|
October 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.